Jump to main content
Jump to site search


Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines

Author affiliations

Abstract

Cyclopeptides have been recently used successfully as carriers for the multivalent presentation of carbohydrate and peptide antigens in immunotherapy. Beside their synthetic versatility, these scaffolds are indeed interesting due to their stability against enzyme degradation and low immunogenicity. This mini-review highlights the recent advances in the utilization of cyclopeptides to prepare fully synthetic vaccines prototypes against cancers and pathogens.

Graphical abstract: Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 25 Jan 2017, accepted on 03 Mar 2017, published on 09 Mar 2017 and first published online on 09 Mar 2017


Article type: Minireview
DOI: 10.1039/C7BM00072C
Citation: Biomater. Sci., 2017, Advance Article
  •   Request permissions

    Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines

    C. Pifferi, N. Berthet and O. Renaudet, Biomater. Sci., 2017, Advance Article , DOI: 10.1039/C7BM00072C

Search articles by author